Suppression of tumor necrosis factor alpha and vascular...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61K 31/00 (2006.01) A61K 31/505 (2006.01) A61K 38/17 (2006.01) C07K 16/24 (2006.01)

Patent

CA 2290021

Methods for treating and/or preventing a TNF-mediated disease in an individual are disclosed. Also disclosed are compositions comprising a TNF.alpha. antagonist and a VEGF antagonist. TNF-mediated diseases include rheumatoid arthritis, Crohn's disease, and acute and chronic immune diseases associated with transplantation.

L'invention concerne des procédés permettant de traiter et/ou d'empêcher une maladie associée au facteur de nécrose tumorale (TNF) chez un individu. L'invention concerne également des compositions contenant un antagoniste du TNF.alpha. et un antagoniste du facteur de croissance des cellules endothéliales vasculaires (VEGF). Parmi les maladies médiées par le TNF on trouve la polyarthrite rhumatoïde, la maladie de Crohn ainsi que des troubles immunologiques aigus et chroniques associés à une greffe.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Suppression of tumor necrosis factor alpha and vascular... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Suppression of tumor necrosis factor alpha and vascular..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Suppression of tumor necrosis factor alpha and vascular... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1554441

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.